News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
News Conference News TCT 2023 TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER Yael L. Maxwell October 26, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Conference News TCT 2019 From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection Yael L. Maxwell September 25, 2019
News Conference News TCT 2018 Novel LAA Closure Device Shows Promise in Early Experience L.A. McKeown September 22, 2018
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News TCT 2016 TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function Todd Neale November 01, 2016
Presentation TCT 2015 TCT 22: Patent and Occluded Saphenous Vein Grafts as Retrograde Conduits for Percutaneous Revascularization of Coronary Chronic Total Occlusions: The Quebec Experience Presenter: Eric A. Cohen, Truls Råmunddal, Rustem Dautov October 13, 2015
News Conference News TCT 2015 Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients October 13, 2015
News Conference News TCT 2015 V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF October 11, 2015
News Features TCT 2014 Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease Todd Neale October 24, 2014
News Conference News TCT 2014 Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk September 13, 2014
News Conference News SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel November 21, 2011